FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE ATOM PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2003030 · Received February 28, 2011

Report

Report Number
2134265-2011-00647
Event Type
Injury
Date Received
February 28, 2011
Date of Event
December 21, 2010
Report Date
February 1, 2011
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PATIENT IDENTIFIER: (B)(6). DEVICE IS COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

(B)(6). IT WAS REPORTED THAT FOLLOWING A CORONARY STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED A MYOCARDIAL INFARCTION (MI). THE INDEX PROCEDURE TREATED THE 100% STENOSED, 2.5X22MM TARGET LESION LOCATED IN THE 3RD OBTUSE MARGINAL BRANCH WITH TIMI 0 FLOW. TREATMENT CONSISTED OF PRE DILATION AND THE PLACEMENT OF A 2.5X20MM TAXUS LIBERTE STUDY STENT RESULTING IN 0% RESIDUAL STENOSIS AND TIMI 3 FLOW. POST THE INDEX PROCEDURE AND PRIOR TO DISCHARGE THE PATIENT HAD ELEVATED ENZYMES THAT MET THE PROTOCOL DEFINITION OF AN MI. NO ACTION WAS TAKEN AND THE SUBJECT WAS DISCHARGED LATER THE SAME DAY ON ASPIRIN AND PRASUGREL. PER THE PHYSICIAN, THE EVENT WAS LISTED AS "RELATED" TO THE STUDY STENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS LIBERTE ATOM PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - GALWAY H7493893628220 12795511

Patients

Seq Age Sex Outcome Treatment
1 43 YR Other